FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

37411004: Tissue plasminogen activator (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
62404015 Tissue plasminogen activator en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
62405019 T-PA en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
769275011 Tissue plasminogen activator (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
62404015 Tissue plasminogen activator en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
62404015 Tissue plasminogen activator en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
62405019 T-PA en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
769275011 Tissue plasminogen activator (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
769275011 Tissue plasminogen activator (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tissue plasminogen activator Is a Plasminogen activator false Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator Is a Substance with hydrolase mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator Has disposition Hydrolase false Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator Has disposition Plasminogen activator (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator Is a Enzyme activator true Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator Is a proteasi false Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator Is a Protein true Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator Is a Peptide hydrolase true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
tPA-PAI complex assay Has measured component False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator assay Has measured component False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator activity assay Has measured component False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator antigen assay Has measured component False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator antigen Direct substance False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
tPA-PAI complex assay Component False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 2
Tissue plasminogen activator assay Component True Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 1
Tissue plasminogen activator activity assay Component True Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 1
Tissue plasminogen activator antigen assay Component True Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 1
Reteplase (substance) Is a False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Alteplase (substance) Is a False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Tenecteplase (substance) Is a False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing tissue plasminogen activator (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing reteplase (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Alteplase 50mg injection (pdr for recon)+diluent (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Alteplase 20mg injection (pdr for recon)+diluent (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
alteplase 10 mg, fiole de poudre et solvant pour solution pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Reteplase 10units injection (pdr for recon)+diluent pack (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing tenecteplase (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing alteplase (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Tenecteplase 8000iu(40mg) injection (pdr for recon)+solvent (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Tenecteplase 10,000iu(50mg) inj (pdr for recon)+solvent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Alteplase 1mg injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Reteplase, recombinant 10unt/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Alteplase 100mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept)
Tissue plasminogen activator only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 1
Fibrinolytic disorder caused by tissue plasminogen activator Causative agent (attribute) True Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 2
Intravenous injection of tissue plasminogen activator Direct substance True Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 1
Intra-arterial injection of tissue plasminogen activator Direct substance True Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 1
Adverse reaction caused by tissue plasminogen activator (disorder) Causative agent (attribute) True Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 1
tPA-PAI complex assay Component True Tissue plasminogen activator Inferred relationship Existential restriction modifier (core metadata concept) 1

Reference Sets

GB English

US English

Back to Start